S1+ Paclitaxel (IV&IP) + Bevacizumab (IP) Versus S1+Oxaliplatin as First-line Treatment in Gastric Cancer With Malignant Ascites
Clinical trial NCT03990103 · UNKNOWN
Trial details
- NCT number
- NCT03990103
- Sponsor
- China Medical University, China
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-01
- Primary completion
- 2021-04-30
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.